Global Leader in Allogeneic Cellular Medicines for Inflammatory Diseases Financial and Operational Highlights for the Third Quarter Ended March 31, 2020 ASX: MSB; Nasdaq: MESO CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ ma ...

Mesoblast Limited (NASDAQ:MESO) Q2 2020 Earnings Conference Call February 26, 2020 4:30 PM ET Company Participants Silviu Itescu - Chief Executive Officer Josh Muntner - Chief Financial Officer Conference Call Participants Louise Chen - Cantor Jason Kolbert - Dawson James Tanushree Jain - Bell Potter Securities Marc Sinatra - Lodge partners Operator Hello and welcome to Mesoblast???s Financial Results Webcast for the Six Months Ended December 31, 2019. An announcement and slide presentation have been lodged ...

Mesoblast Limited (NASDAQ:MESO) Q1 2020 Earnings Conference Call November 25, 2019 4:30 PM ET Company Participants Silviu Itescu - Chief Executive Officer and Managing Director Josh Muntner - Chief Financial Officer Conference Call Participants Louise Chen - Cantor Fitzgerald Jeffrey Cohen - Ladenburg Thalmann Tanushree Jain - Bell Potter Securities Operator Hello, and welcome to Mesoblast???s Financial Results Webcast for the Quarter Ended September 30, 2019. An announcement and slide presentation have bee ...

blast Global Leader in Allogeneic Cellular Medicines for Inflammatory Diseases FY Ended June 30, 2019 Nasdaq: MESO ASX: MSB CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity ...

Mesoblast Limited (NASDAQ:MESO) Q4 2019 Earnings Conference Call August 29, 2019 6:00 PM ET Company Participants Silviu Itescu ??? Chief Executive Officer Josh Muntner ??? Chief Financial Officer Conference Call Participants Jeffrey Cohen ??? Ladenburg Kalpit Patel ??? Oppenheimer Swayampakula Ramakanth ??? H.C. Wainwright Tanushree Jain ??? Bell Potter Securities Nicolette Quinn ??? Morningstar Marc Sinatra ??? Lodge Partners Operator Hello, and welcome to Mesoblast???s Financial Update and Operational Hig ...

Operational Highlights and Financial Results for the Nine Months and Quarter Ended March 31, 2019 May 2019 Nasdaq: MESO ASX: MSB CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of act ...

Mesoblast (NASDAQ:MESO) Q3 2019 Earnings Conference Call May 30, 2019 4:30 PM ET Company Participants Silviu Itescu ??? Chief Executive Officer Josh Muntner ??? Chief Financial Officer Joanne Kurtzberg ??? Distinguished Professor of Pediatrics Conference Call Participants Mark Breidenbach ??? Oppenheimer Jason McCarthy ??? Maxim Group Jeffrey Cohen ??? Ladenburg Thalmann Operator Hello, and welcome to Mesoblast's Financial Update and Operational Highlights Webcast for the Third Quarter Ended March 31, 2019. ...

Global Leader in Cellular Medicines for Inflammatory Diseases March 2019 Nasdaq: MESO ASX: MSB CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements ...

Operational Highlights and Financial Results for the Half Year Ended December 31, 2018 February 2019 Nasdaq: MESO ASX: MSB CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, ...

Mesoblast (NASDAQ:MESO) First Half Year and Second Quarter Ended December 31, 2018 Earnings Conference Call February 20, 2019 4:30 PM ET Company Participants Silviu Itescu ??? Chief Executive Officer Josh Muntner ??? Chief Financial Officer Andrew Chaponnel ??? Head-Finance Conference Call Participants Mark Breidenbach ??? Oppenheimer Jason McCarthy ??? Maxim Group Tanu Jain ??? Bell Potter Securities David Langsam ??? Biotech Daily RK Swayampakula ??? H.C. Wainwright Operator Hello, and welcome to Mesobl ...